Intensifying Long-Acting β-Agonist/Corticosteroid Therapy at Acute Exacerbations of Chronic Obstructive Pulmonary Disease

Affiliations

¹ 1 National Heart and Lung Institute Imperial College London London, United Kingdom and.
² 2 Division of Pulmonary and Critical Care Medicine Weill Cornell Medical College of Cornell University New York, New York.

Free article

Editorial

Jadwiga A Wedzicha et al. Am J Respir Crit Care Med. 2018.

Free article

. 2018 May 1;197(9):1096-1098.

doi: 10.1164/rccm.201801-0202ED.

¹ 1 National Heart and Lung Institute Imperial College London London, United Kingdom and.
² 2 Division of Pulmonary and Critical Care Medicine Weill Cornell Medical College of Cornell University New York, New York.

No abstract available

Comment on

Intensified Therapy with Inhaled Corticosteroids and Long-Acting β₂-Agonists at the Onset of Upper Respiratory Tract Infection to Prevent Chronic Obstructive Pulmonary Disease Exacerbations. A Multicenter, Randomized, Double-Blind, Placebo-controlled Trial.
Stolz D, Hirsch HH, Schilter D, Louis R, Rakic J, Boeck L, Papakonstantinou E, Schindler C, Grize L, Tamm M. Stolz D, et al. Am J Respir Crit Care Med. 2018 May 1;197(9):1136-1146. doi: 10.1164/rccm.201709-1807OC. Am J Respir Crit Care Med. 2018. PMID: 29266965 Clinical Trial.